These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37186134)

  • 21. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
    Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
    Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
    Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
    Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
    Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.
    Xu R; Spencer VA; Bissell MJ
    J Biol Chem; 2007 May; 282(20):14992-9. PubMed ID: 17387179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transcription of the main gene associated with Treacher-Collins syndrome (TCOF1) is regulated by G-quadruplexes and cellular nucleic acid binding protein (CNBP).
    Gil Rosas M; Centola C; Torres M; Mouguelar VS; David AP; Piga EJ; Gomez D; Calcaterra NB; Armas P; Coux G
    Sci Rep; 2024 Mar; 14(1):7472. PubMed ID: 38553547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Interaction between the SWI/SNF Chromatin Remodeling Complex and the Zinc Finger Factor CTCF.
    Valletta M; Russo R; Baglivo I; Russo V; Ragucci S; Sandomenico A; Iaccarino E; Ruvo M; De Feis I; Angelini C; Iachettini S; Biroccio A; Pedone PV; Chambery A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription.
    Chen S; Su L; Qiu J; Xiao N; Lin J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2013 Oct; 1830(10):4769-77. PubMed ID: 23774591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
    Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
    J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
    Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
    Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways.
    Jubierre L; Soriano A; Planells-Ferrer L; París-Coderch L; Tenbaum SP; Romero OA; Moubarak RS; Almazán-Moga A; Molist C; Roma J; Navarro S; Noguera R; Sánchez-Céspedes M; Comella JX; Palmer HG; Sánchez de Toledo J; Gallego S; Segura MF
    Oncogene; 2016 Sep; 35(39):5179-90. PubMed ID: 26996667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.
    Wang X; Guo Y; Chen G; Fang E; Wang J; Li Q; Li D; Hu A; Bao B; Zhou Y; Gao H; Song J; Du X; Zheng L; Tong Q
    Oncogene; 2023 Sep; 42(36):2673-2687. PubMed ID: 37537343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
    Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
    J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
    Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
    Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SWI/SNF protein component BAF250a regulates cardiac progenitor cell differentiation by modulating chromatin accessibility during second heart field development.
    Lei I; Gao X; Sham MH; Wang Z
    J Biol Chem; 2012 Jul; 287(29):24255-62. PubMed ID: 22621927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.